Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone

Endocrinology
J HallChris Peers

Abstract

Testosterone has marked beneficial cardiovascular effects, many of which have been attributed to a vasodilatory action. However, the molecular target of testosterone underlying this effect is subject to debate. In this study, we have used microfluorimetry as a noninvasive means of examining whether testosterone could exert dilatory effects via inhibition of voltage-gated Ca2+ entry in the model vascular smooth muscle cell line, A7r5. Rises of [Ca2+]i evoked by 50 mm K+ -containing solution were suppressed in a concentration-dependent manner by testosterone (IC50, 3.1 nm) and by the nonaromatizable analog, 5beta-dihydrotestosterone (IC50, 6.9 nm). The effects of testosterone were apparent in the presence of pimozide (to block T-type Ca2+ channels) but not nifedipine (to block L-type Ca2+ channels). Testosterone did not alter Ca2+ mobilization from intracellular stores by the prostaglandin analog U46619 or capacitative Ca2+ entry in cells pretreated with thapsigargin. Our results indicate that testosterone, at physiological concentrations, can selectively suppress Ca2+ entry into A7r5 cells via L-type Ca2+ channels. We suggest this effect is a likely mechanism underlying its vasodilatory actions and beneficial cardiovascular effe...Continue Reading

References

Feb 1, 1983·American Journal of Epidemiology·D L WingardE Barrett-Connor
Feb 15, 1995·Circulation·P YueP Collins
Dec 1, 1996·European Heart Journal·R D DickermanN Y Zachariah
May 22, 1997·The American Journal of Cardiology·W H Frishman, M D Michaelson
Mar 11, 1999·The American Journal of Cardiology·C M WebbP Collins
Apr 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J K Crews, R A Khalil
Jun 5, 1999·European Journal of Pharmacology·M Perusquía, C M Villalón
Jun 11, 1999·The New England Journal of Medicine·M E Mendelsohn, R H Karas
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·A VermeulenJ M Kaufman
Dec 6, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·K M EnglishK S Channer
Feb 9, 2002·British Journal of Pharmacology·Patcharin Tep-areenanMichael D Randall
May 22, 2002·Journal of Cardiovascular Pharmacology·Richard D JonesKevin S Channer
May 31, 2002·Journal of Endocrinological Investigation·K M EnglishK S Channer
Jun 6, 2002·The Journal of Biological Chemistry·Zhiyong GuoFrank Wunderlich
Jan 22, 2003·European Journal of Endocrinology·Richard D JonesT Hugh Jones
Mar 19, 2003·British Journal of Pharmacology·Richard D JonesKevin S Channer
Apr 26, 2003·European Heart Journal·Peter J PughKevin S Channer
Dec 6, 2003·Pharmacological Reviews·William A CatterallUNKNOWN International Union of Pharmacology
Mar 17, 2004·Heart·P J PughK S Channer
May 4, 2004·Biochemical and Biophysical Research Communications·Jason L ScraggChris Peers
Aug 25, 2005·Clinical Endocrinology·D KapoorT H Jones

❮ Previous
Next ❯

Citations

Nov 21, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Elisa CairrãoIgnacio Verde
Feb 3, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masahiro Akishita, Jing Yu
Apr 18, 2013·Nature Reviews. Endocrinology·Matthew SpitzerShalender Bhasin
Jan 3, 2013·Clinical and Experimental Pharmacology & Physiology·Paulo A SaldanhaIgnacio Verde
Mar 17, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Mercedes Perusquía, John N Stallone
Apr 12, 2012·The Journal of Endocrinology·Yasumasa IkedaToshio Matsumoto
Apr 4, 2013·The Journal of Endocrinology·Daniel M Kelly, T Hugh Jones
Jun 23, 2009·European Journal of Endocrinology·Atish MathurKevin Channer
May 23, 2014·Menopause : the Journal of the North American Menopause Society·Darla L TharpDouglas K Bowles
May 9, 2014·Journal of Cardiovascular Pharmacology·Joana FeiteiroElisa Cairrão
Oct 1, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Marcos Antônio A MedeirosJader S Cruz
Apr 21, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Chris J MalkinT Hugh Jones
Dec 10, 2015·The Journal of Sexual Medicine·Biljana MusickiArthur L Burnett
May 7, 2010·European Journal of Pharmacology·Elisa CairrãoIgnacio Verde
Apr 13, 2010·Trends in Endocrinology and Metabolism : TEM·T H Jones
Dec 15, 2010·Advances in Pharmacological Sciences·E AlvarezI Verde
Nov 13, 2007·Trends in Endocrinology and Metabolism : TEM·Faisal Rahman, Helen C Christian
Nov 7, 2007·Frontiers in Neuroendocrinology·Guido Michels, Uta C Hoppe
Dec 19, 2006·Cell Calcium·Jason L ScraggChris Peers
Jun 28, 2013·British Journal of Pharmacology·K M MairM R MacLean
Nov 23, 2010·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Sarah TorklerRobin Haring
Jun 17, 2015·Current Urology Reports·Kevin Matthew Yen Bing LeungSerge Carrier
May 30, 2014·Pflügers Archiv : European journal of physiology·Mercedes PerusquíaLuis M Montaño
Mar 13, 2018·Endocrine Research·Lucía IsidoroMercedes Perusquía
Mar 18, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jaime Ribeiro-FilhoPatrícia T Bozza
Sep 5, 2013·Molecular Endocrinology·María C González-MontelongoMario Díaz
Apr 19, 2019·Expert Opinion on Drug Safety·G CoronaM Maggi
Nov 13, 2014·Hormone Molecular Biology and Clinical Investigation·Roger Lyrio dos SantosIvanita Stefanon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.